Page last updated: 2024-11-04

dimethylaniline n-oxide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

dimethylaniline N-oxide: RN given refers to parent cpd; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

N,N-dimethylaniline N-oxide : A member of the class of dimethylanilines that is N,N-dimethylaniline in which the tertiary amino group has been oxidised to give the corresponding N-oxide. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID950
CHEBI ID17735
SCHEMBL ID1537731
MeSH IDM0046468

Synonyms (23)

Synonym
CHEBI:17735
dimethyl(phenyl)amine oxide
874-52-2
dimethylaniline n-oxide
NN-DIMETHYLANILINE-N-OXIDE ,
n,n-dimethylaniline-n-oxide
inchi=1/c8h11no/c1-9(2,10)8-6-4-3-5-7-8/h3-7h,1-2h
C01183
n,n-dimethylaniline n-oxide
n,n-dimethylbenzeneamine oxide
n3q9ln57gp ,
einecs 212-863-2
unii-n3q9ln57gp
AKOS025296244
dimethylaniline oxide
benzenamine, n,n-dimethyl-, n-oxide
aniline, n,n-dimethyl-, n-oxide
n,n-dimethylaniline oxide
SCHEMBL1537731
dimethylaniline-n-oxide
(dimethylnitroso)benzene
DTXSID60236323
Q27102568
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
dimethylanilineA methylaniline carrying at least two methyl groups.
tertiary amine oxideAn N-oxide where there are three organic groups bonded to the nitrogen atom.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (1)

PathwayProteinsCompounds
1q21.1 copy number variation syndrome07

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (16.67)18.7374
1990's2 (33.33)18.2507
2000's1 (16.67)29.6817
2010's2 (33.33)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.25

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.25 (24.57)
Research Supply Index2.30 (2.92)
Research Growth Index4.55 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.25)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other9 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]